Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Christiane Stern, Laurent Castera

Clin Mol Hepatol. 2023;29(Suppl):S196-S206. Published online December 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0431

View: 5308 Download: 271 Web of Science: 8 Crossref: 9

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9535 Download: 125 Web of Science: 24 Crossref: 26

Grace Lai-Hung Wong

Clin Mol Hepatol. 2014;20(3):228-236. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.228

View: 13173 Download: 98 Web of Science: 37 Crossref: 36

Kyu Sik Jung, Seung Up Kim

Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.163

View: 11661 Download: 121 Crossref: 79

1 |

Viewed By 5540	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4729	MAFLD: How is it different from NAFLD?
Viewed By 4456	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3658	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3627	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search